for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Varian Medical Systems, Inc.

VAR.N

Latest Trade

172.41USD

Change

-0.55(-0.32%)

Volume

397,485

Today's Range

172.15

 - 

172.98

52 Week Range

89.62

 - 

176.11

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
172.96
Open
172.50
Volume
397,485
3M AVG Volume
35.31
Today's High
172.98
Today's Low
172.15
52 Week High
176.11
52 Week Low
89.62
Shares Out (MIL)
91.16
Market Cap (MIL)
15,767.27
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q1 2021 Varian Medical Systems Inc Earnings Release

Latest Developments

More

Varian Reports Results For Fourth Quarter Of Fiscal Year 2020

Siemens Healthineers Receives U.S. Antitrust Clearance For Proposed Merger With Varian

Varian Medical Reaches Agreement To Resolve Certain Actions In Exchange For Making Certain Disclosures & Revised Proxy Statement

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Varian Medical Systems, Inc.

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, cardiac radioablation, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product. Through its subsidiary, Cooperative CL Enterprises, the Company distributes radiotherapy equipments in Taiwan.

Industry

Medical Equipment & Supplies

Contact Info

3100 Hansen Way Bldg 4A

PALO ALTO, CA

94304-1038

United States

+1.650.4934000

https://www.varian.com/

Executive Leadership

R. Andrew Eckert

Independent Chairman of the Board

Chris A. Toth

President, Chief Operating Officer

Dow R. Wilson

Chief Executive Officer, Director

J. Michael Bruff

Chief Financial Officer, Senior Vice President - Finance

Francis Facchini

President, Interventional Solutions Business

Key Stats

2.33 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

2.7K

2018

2.9K

2019

3.2K

2020(E)

3.1K
EPS (USD)

2017

3.600

2018

4.420

2019

4.630

2020(E)

3.765
Price To Earnings (TTM)
60.74
Price To Sales (TTM)
4.93
Price To Book (MRQ)
8.13
Price To Cash Flow (TTM)
42.47
Total Debt To Equity (MRQ)
30.62
LT Debt To Equity (MRQ)
0.46
Return on Investment (TTM)
11.35
Return on Equity (TTM)
6.19

Latest News

Latest News

Siemens Healthineers raises 2.73 billion euro from share sale to fund Varian deal

Siemens Healthineers <SHLG.DE> said on Wednesday it issued 2.73 billion euros ($3.22 billion) worth of new shares to help finance its planned takeover of U.S. peer Varian <VAR.N>.

Siemens Healthineers in first 2.9 bln euro cash call to fund Varian deal

Siemens Healthineers on Wednesday launched a 2.9 billion euro ($3.43 billion) capital increase to finance parts of the planned takeover of U.S. peer Varian.

Siemens Healthineers plans two-step 7.5 billion euro capital hike for Varian acquisition - sources

Siemens Healthineers <SHLG.DE> plans a two-step capital increase to raise 7.5 billion euros ($8.80 billion) via share placements to help finance its acquisition of Varian Medical Systems <VAR.N>, sources close to the matter said on Monday.

Siemens Healthineers expands into cancer care with $16.4 billion deal for Varian

German health group Siemens Healthineers said on Sunday it was buying Varian Medical Systems Inc of the United States for $16.4 billion in a deal that seeks to create the global leader in cancer care solutions.

Siemens Healthineers to acquire Varian for $16.4 billion

German health group Siemens Healthineers said on Sunday it would acquire Varian Medical Systems Inc in a deal that values the U.S. maker of devices and software for treating cancer at $16.4 billion.

Siemens Healthineers in advanced talks to buy Varian for $15 billion - Bloomberg News

German group Siemens Healthineers AG is in advanced talks to purchase Varian Medical Systems Inc, a maker of devices and software for treating cancer, in a deal that will value the medical device maker at about $15 billion (11.5 billion pounds), Bloomberg News reported late...

Eni, HitecVision-backed Var seeks $1 billion for production vessel: source

Norwegian oil and gas producer Var Energi, backed by Eni <ENI.MI> and private equity firm HitecVision, is seeking around $1 billion for its Jotun production ship, a source with direct knowledge of the matter told Reuters.

BRIEF-Varian Medical Says Results Demonstrate Effectiveness Of Stereotactic Ablative Radiotherapy To Treat Metastatic Cancers

* LONG-TERM RESULTS FROM SABR-COMET FURTHER DEMONSTRATE EFFECTIVENESS OF STEREOTACTIC ABLATIVE RADIOTHERAPY FOR COMPREHENSIVE TREATMENT OF METASTATIC CANCERS

BRIEF-RaySearch Enters Into Interoperability Agreement With Varian

* RAYSEARCH ENTERS INTO INTEROPERABILITY AGREEMENT WITH VARIAN

BRIEF-Varian Medical Systems Center In Singapore Expanding Access To Radiation Therapy Technology

* VARIAN MEDICAL SYSTEMS INC - CENTER IN SINGAPORE EXPANDING ACCESS TO RADIATION THERAPY TECHNOLOGY Source text for Eikon: Further company coverage:

BRIEF-Varian Halcyon 2.0 Treatment System Receives China NMPA Approval

* VARIAN HALCYON 2.0 TREATMENT SYSTEM RECEIVES CHINA NMPA APPROVAL Source text for Eikon: Further company coverage:

BRIEF-Quebec Selects Varian To Increase Access To Advanced Cancer Care

* QUEBEC SELECTS VARIAN TO INCREASE ACCESS TO ADVANCED CANCER CARE

BRIEF-Varian Says COVID-19 Outbreak Will Negatively Impact Operating Results

* COVID-19 OUTBREAK WILL NEGATIVELY IMPACT COMPANY'S OPERATING RESULTS

BRIEF-Varian Medical Systems Amended By-Laws To Provide That Any Director May Be Removed

* VARIAN MEDICAL SYSTEMS - AMENDED BY-LAWS TO PROVIDE THAT ANY DIRECTOR MAY BE REMOVED, BY VOTE OF HOLDERS OF AT LEAST A MAJORITY VOTING POWER Source text: (https://bit.ly/2PY4doX) Further company coverage:

Australia's Sirtex clears U.S. regulatory hurdle for Chinese buyout

Liver cancer treatment maker Sirtex Medical <SRX.AX> said on Monday that the U.S. Federal Trade Commission cleared its $1.4 billion buyout by a Chinese consortium, clearing a major hurdle for the deal to go through.

Australia's Sirtex picks $1.4 billion Chinese bid over Varian offer

Australia's Sirtex Medical <SRX.AX> has picked the highest bidder in a takeover battle for the liver cancer specialist, going with a $1.4 billion Chinese offer that trumped U.S. company Varian Medical Systems <VAR.N>.

Varian says will not match Chinese bid for Australia's Sirtex

Varian Medical Systems <VAR.N> said it would not increase its offer to buy Australian liver cancer treatment provider Sirtex Medical Ltd <SRX.AX> after Sirtex on Tuesday said Chinese private equity firm CDH Investments had submitted a formal bid.

BRIEF-Varian notifies Sirtex it will not submit a counterproposal to competing bid

* VARIAN NOTIFIES SIRTEX IT WILL NOT SUBMIT A COUNTERPROPOSAL TO COMPETING BID

BRIEF-Varian Acquires Taiwan Distributor

* VARIAN MEDICAL SYSTEMS INC - ACQUIRED COOPERATIVE CL ENTERPRISES, A DISTRIBUTOR OF RADIOTHERAPY EQUIPMENT IN TAIWAN Source text for Eikon: Further company coverage:

Chinese firm makes last-minute $1.4 billion offer for Australia's Sirtex, trumps Varian

Chinese private equity firm CDH Investments lobbed a last-minute $1.4 billion offer for Australian liver-cancer treatment firm Sirtex Medical <SRX.AX>, trumping Varian Medical Systems <VAR.N> days before the U.S. firm was set to seal a takeover deal.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up